β-2′- or 3′-halonucleosides
US6949522B2 · kind B2 · utility
44Cited by
23References
44Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 24, 2002 |
| Grant date | Sep 27, 2005 |
| Priority date | — |
| Expiry date | Jun 24, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes compounds and compositions of β-halonucleosides, as well as methods to treat HIV, HBV or abnormal cellular proliferation comprising administering said compounds or compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.